Inova Translational Medicine Institute

Name

Inova Translational Medicine Institute

Legal name

Inova

Website

https://inova.org

Company type

Private

Founded year

1961

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Translational Medicine Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Translational Medicine & Biomarkers (HLAIALAF)

akta.pro secondary industries

Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)

Keywords

• Translational medicine research
• Genomics research
• Personalized medicine
• Clinical research services
• Biomedical research

Headquarters

HQ city

Fairfax

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Healthcare Services Revenue: Inova generates revenue through providing integrated healthcare services including hospital care, emergency services, primary and specialty care, outpatient services, and diagnostic services. Services are billed through insurance plans, Medicare, Medicaid, and direct patient payments.
2. Blood Donor Services: Inova Blood Donor Services collects and processes blood donations for transfusions and medical procedures.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels5 records

Core offering

Inova Translational Medicine Institute conducts genomics and translational medicine research as part of the Inova Health System nonprofit, transforming healthcare through groundbreaking genomic discoveries translated into clinical applications. The institute applies personalized medicine approaches to advance patient outcomes and collaborates with academic institutions, clinicians, and researchers on translational research programs.

Product overview

Inova is a nonprofit healthcare system providing integrated healthcare services through a network of hospitals, primary and specialty care practices, emergency and urgent care centers, and outpatient services. The organization's offerings include specialized medical services (Neurosciences, Neurology, Surgery, Interventional Radiology), rehabilitation services (Physical Therapy Centers), professional development programs (RN Residency, Nurse Externship, IR Technologist Training), and advanced medical simulation facilities (ASTEC, ICAMS). The system is undergoing significant expansion with new facilities in the Eastern Region through 2028.

Differentiator

Problem solved

Functional benefit

Products and services

• Genomics and Translational Medicine Research

Quantifiable outcome

• 4 million+ annual patient visits
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered minor.

• Washington NationalsminorGTM or Marketing PartnerInova serves as the official health system for the Washington Nationals MLB team, providing medical care and health services for team members.
• George Mason University AthleticsminorGTM or Marketing PartnerInova provides healthcare services as the official partner for George Mason University athletics.
• Drexel UniversityminorStrategic or Co-development PartnerNursing education partnership allowing students to participate in clinical rotations at Inova facilities.
• Virginia's Leading Academic InstitutionsminorStrategic or Co-development PartnerCollaboration with Virginia's leading academic institutions for neuroscience research and clinical study investigators.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Scripps Research Translational Institute: Translational medicine institute within Scripps Research focused on genomic and digital medicine research bridging bench and bedside. Closely comparable in mission, funding model (NIH/NCATS CTSA), and translational genomics orientation.
• HudsonAlpha Institute for Biotechnology: Nonprofit genomics and clinical sequencing research institute with translational medicine programs. Comparable as a nonprofit research institute focused on genomics-based discovery and clinical translation.
• Jackson Laboratory: Independent nonprofit biomedical research institute specializing in mammalian genetics and translational genomics. Comparable as a nonprofit research institute with a translational medicine focus and similar NIH funding profile.
• Institute for Systems Biology (ISB): Nonprofit systems biology and translational research institute focused on multi-omic and clinical research. Comparable as a nonprofit translational research organization with genomics and biomarker discovery programs.
• Translational Genomics Research Institute (TGen): Nonprofit translational genomics research institute focused on translating genomic discoveries into clinical applications. Directly comparable to ITMI in mission, structure, and translational research focus, though TGen is part of City of Hope.
• Geisinger MyCode / Geisinger Research: Health-system-embedded genomic medicine and biobanking program integrated with Geisinger's clinical operations. Highly comparable in being a health-system-integrated translational genomics program with large patient cohorts.

Others

• National Institutes of Health (NIH) intramural translational programs: Federal funder and operator of large translational medicine programs including NCATS and NHGRI. Relevant as the dominant translational research funding source and competitive publication benchmark for ITMI.

Emerging players

• Regeneron Genetics Center: Industry-led large-scale human genetics research center embedded in Regeneron, focused on translating genetic discoveries into therapeutic targets. Comparable in genomics/translational focus but operates with substantially more capital and proprietary data assets.
• Icahn Institute for Genomics and Multiscale Biology (Mount Sinai): Genomics and translational medicine institute embedded within a large academic health system. Comparable as a translational genomics program with clinical integration, though backed by a larger academic medical center.

Broad incumbents

• Geisinger / Inova-style Regional Health Systems with Research Arms: Large nonprofit regional health systems (e.g., MedStar Health, Sentara Healthcare, Johns Hopkins Medicine) that operate integrated research programs within their clinical footprint. Comparable in scale, regional concentration, and clinical-research integration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/inovahealth
• Facebookfacebook.com/inova-health-system
• LinkedInlinkedin.com/company/inova-health-system

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries12 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inova Translational Medicine Institute